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Abstract
Background: Recent advances in genomic technologies have facilitated genome-wide investigation of human
genetic variations. However, most efforts have focused on the major populations, yet trio genomes of indigenous
populations from Southeast Asia have been under-investigated.
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Results: We analyzed the whole-genome deep sequencing data (~ 30×) of five native trios from Peninsular
Malaysia and North Borneo, and characterized the genomic variants, including single nucleotide variants (SNVs),
small insertions and deletions (indels) and copy number variants (CNVs). We discovered approximately 6.9 million
SNVs, 1.2 million indels, and 9000 CNVs in the 15 samples, of which 2.7% SNVs, 2.3% indels and 22% CNVs were
novel, implying the insufficient coverage of population diversity in existing databases. We identified a higher
proportion of novel variants in the Orang Asli (OA) samples, i.e., the indigenous people from Peninsular Malaysia,
than that of the North Bornean (NB) samples, likely due to more complex demographic history and long-time
isolation of the OA groups. We used the pedigree information to identify de novo variants and estimated the
autosomal mutation rates to be 0.81 × 10− 8 – 1.33 × 10− 8, 1.0 × 10− 9 – 2.9 × 10− 9, and ~ 0.001 per site per
generation for SNVs, indels, and CNVs, respectively. The trio-genomes also allowed for haplotype phasing with high
accuracy, which serves as references to the future genomic studies of OA and NB populations. In addition, high-
frequency inherited CNVs specific to OA or NB were identified. One example is a 50-kb duplication in DEFA1B
detected only in the Negrito trios, implying plausible effects on host defense against the exposure of diverse
microbial in tropical rainforest environment of these hunter-gatherers. The CNVs shared between OA and NB
groups were much fewer than those specific to each group. Nevertheless, we identified a 142-kb duplication in
AMY1A in all the 15 samples, and this gene is associated with the high-starch diet. Moreover, novel insertions
shared with archaic hominids were identified in our samples.
Conclusion: Our study presents a full catalogue of the genome variants of the native Malaysian populations, which
is a complement of the genome diversity in Southeast Asians. It implies specific population history of the native
inhabitants, and demonstrated the necessity of more genome sequencing efforts on the multi-ethnic native groups
of Malaysia and Southeast Asia.
Background
The rapid development of genome sequencing tech-
nology and analysis capabilities has spawned large
scale human genome sequencing projects in recent
years, for instance, the 1000 Genomes Project, the Simons
Genome Diversity Project, the Estonian Biocentre Human
Genome Diversity Project, UK10K Project, the All of Us
Research Program (https://allofus.nih.gov/), and others
[1–4]. A major undertaking of these projects is to conduct
a comprehensive inventory of all detectable variations of
global modern human populations, which is important for
characterizing the human genetic diversity as well as iden-
tifying disease risk variants. The fine-scale analyses of the
human genome require accurate identification of variants,
imputation and phasing of genotypes, which may be
greatly facilitated by increasing the sequencing depth and
using pedigree information, especially for genomic regions
containing large and complex variations like structural
variants (SVs) and small insertions and deletions (indels)
[5]. In addition, the trio information allows verification of
the detected variants using Mendel’s law of inheritance
and detecting de novo mutations. Understanding the
rates and patterns of de novo mutations is important
for analyzing the population relationship [6, 7], detect-
ing natural selection [8, 9], and mapping genes under-
lying complex traits [10]. To date, most trio-based
sequencing studies are disease-related [11–13]. Whole-
genome sequencing studies of healthy trios are less
biased than those of the disease-based ones, but
publications on these are rather limited, except for the
one Vietnamese trio and 10 Danish trios that were se-
quenced to high coverage in recent years [14, 15].
Located at the crossroads of Southeast Asia, Malaysia
is rich with human population diversity, including native
Malays and Orang Asli (OA, a collective term of indi-
genous populations) occupying the Peninsular Malaysia,
and over 40 native ethnic groups categorized based on
linguistic and socio-economy practices in North Borneo
[16]. However, these native populations are largely un-
derrepresented in the whole-genome sequencing pro-
jects. The genomic architecture of these populations
were characterized by a handful of SNP-array-based
genome-wide studies [17–22]. Recently, using the whole
genome sequencing data of 12 unrelated individuals, we
have also revealed the population structure and diver-
gence between native populations from Peninsular
Malaysia and North Borneo [23].
In this study, we present the variant catalogue of five
native trios (father-mother-offspring) from Peninsular
Malaysia (OA, including Bateq, Mendriq and Semai) and
North Borneo (NB, including Dusun and Murut) by
whole-genome sequencing to a mean depth of 30×. Our
data revealed a large number of novel genomic variants,
including the single nucleotide variants (SNVs), indels
and copy number variants (CNVs), in the native
Malaysian trios, particularly in OA. The rates of de novo
genomic variants were estimated. In addition, the inher-
ited novel insertions were identified from the unmapped
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reads of these samples, some of which could have been
shared with archaic hominins.
Results
Discovery of SNVs and indels
The five native Malaysian trios were sequenced at cover-
age of 28–38× (~ 30× on average; Additional file 1:
Table S1). One Mendriq (MDQ) sample had the lowest
sequence coverage at 28.3× (Table 1). On average 97.5%
(Phred Score ≥ 10) of the reads were mapped to the ref-
erence genome (GRCh37). As shown in Table 1, more
than 6.9 million SNVs (3.4 million per genome) and ap-
proximately 1.2 million bi-allelic indels (< 100 bp, 0.6
million per genome) were discovered in the fifteen ge-
nomes. The average Ti/Tv ratio was similar across all
the native Malaysian populations (2.1 per genome),
which was consistent with published reports [14, 38, 39].
The individual genome heterozygosity ranged between
51.6–56.7% for SNVs and 59.5–66.8% for indels, lower
than other global populations (Table 1; Fig. 1a), suggest-
ing that the native Malaysian populations are genetically
more homogenous.
We further examined whether there were genomic re-
gions enriched with variants. Hotspots of variants were
determined by selecting the top 1% non-overlapping
windows across the genome, each spanning 1Mb, with
top counts of mutations that passed the quality control
(genotyping quality ≧ 50; read depth = 10–120; allele bal-
ance = 0.3–0.7). SNVs and indels were treated independ-
ently. Regions adjacent to 1Mb from the telomeres and
centromeres were excluded. As expected, the region
Chr6:29–33Mb harboured the largest number of both
SNVs and indels, followed by Chr8:3–4Mb (Additional
file 1: Table S2-S3). These two regions encompass
immunity-related protein-coding genes (the MHC Class
II genes, ANGPT2, DEFA, and DEFB on chromosome 6;
CSMD1 on chromosome 8) [40–42], and have been re-
ported previously as SNV hotspots in the Singapore
Malays [38]. Particularly noteworthy is CSMD1, which is
highly expressed in the brain [43] and may play a role in
the susceptibility of malarial infection [41, 42]. The re-
gion Chr22:49–50Mb was another hotspot of SNVs and
indels, spanning two immune related genes FAM19A5
and C22orf34. Protein-coding genes underlying the mu-
tation hotspots regions were significantly enriched in ol-
faction, immunity and hemoglobin among others
(Additional file 2: Table S4), suggesting that genomic re-
gions which are ‘sensitive’ towards environmental re-
sponses tend to be more variable.
We applied SnpEff version 4.3 T [36] to classify the
variants according to their functional effects, and sum-
marized the number of SNVs and indels of each
category in each population in Additional file 1: Table
S5-S6. We found 98.5% of the SNVs and 99% of the
indels were non-coding variants; while the remains in-
cluded possibly harmful variants with low (1.1% SNVs
and 0.08% indels) and moderate (0.4% SNVs and 0.15%
indels) impact, and disruptive variants with high impact
(0.03% SNVs and 0.07% indels, e.g., exon-loss, frame-
shift, splice-acceptor, splice-donor, start-lost, stop-
gained, stop-lost, and transcript-ablation variants). Each
genome carried 290 loss-of-function (LOF) SNVs on
average (Additional file 1: Table S7), consistent with pre-
viously reported number of LOF variants (200–800) in
each healthy human genome [44]. Although fewer sam-
ples were sequenced, the number of LOF-SNVs in our
data was comparable with that reported in the 1000
Genomes Project data (Additional file 1: Table S5),
which represents a larger sample size with low sequen-
cing depth. When comparing across the five native
Malaysian populations, the number of LOF-SNVs per
genome between OA and NB were similar (291 vs. 289
per sample) (Fig. 1c; Additional file 1: Table S7).
On average, 486 high-impact indels and 320 LOF-
indels were identified in each sample, similar with other
global populations (Fig. 1d; Additional file 1: Table S6-
S7) [45]. Of these, 354 were homozygous deletions in at
least one sample, and 555 indels presented in more than
one sample. Frameshift indels (FS-indels) are generally
thought to be pathogenic and may confer significant
phenotypic consequences [45]. We observed 644 FS-
indels in the 15 samples (on average 327 in each), of
which 171 were homozygous deletion in at least one
sample, and 580 FS-indels presented in more than one
sample. One example of high-frequency FS-indels in the
15 samples is an 11-bp mutation affecting MICA (fre-
quency = 0.87). MICA has been attributed to auto-
immune diseases and viral infection [46, 47]. Details of
the FS-indels identified are tabulated in Additional file 3:
Table S8. Protein-coding genes affected by LOF-indels
showed significant enrichment in Ca2+-dependent cell
adhesion and olfactory transduction (Additional file 2:
Table S4). A similar functional enrichment pattern was
observed on genes overlapping with FS-indels.
Identification of novel SNVs and indels
We observed approximately 0.19 million SNVs (2.7%)
and 0.03 million indels (2.3%) not reported in
dbSNP153. The overall novelty rate across autosomal
chromosomes was similar, ranging from 2.2% (chromo-
some 21) to 3.0% (chromosome 5) for SNVs, and from
2.0% (chromosome 13) to 2.9% (chromosome 22) for
indels. Genomic regions emerged with higher densities
of novel SNVs or indels are listed in Additional file 1:
Table S9-S10. The variant-enriched region Chr8:3–6
Mb, again, harbored the largest number of novel SNVs;
Chr1:145–148Mb showed a substantial excess of novel
indels than other regions.
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Comparing across the native Malaysian populations,
we found that OA populations harbored more novel var-
iants than NB populations did on both population (1.0–
1.6% of SNVs and 1.4–1.7% of indels in OA; 0.5% of
SNVs and 1.2% of indels in NB) and individual (0.7–
1.2% of SNVs and 1.2–1.5% of indels in OA; 0.3% of
SNVs and 1.1% of indels in NB) levels (Table 1; Fig. 1b;
Additional file 1: Table S5-S6). Notably, the two Negrito
populations especially the Bateq (BTQ) trio, harbored
the highest proportion of putative novel SNVs and novel
indels (novelty rates are 1.2% for SNVs and 1.5% for
indels in each BTQ sample) (Additional file 1: Table S5-
S6). OA and NB populations shared a smaller number of
novel SNVs (1323, making up 0.9 and 3.1% of the novel
SNVs in OA and NB, respectively), but more novel
indels (8358, making up 36.4 and 64.7% of the novel
SNVs in OA and NB, respectively) in common.
Estimating de novo mutation rates
We further identified autosomal de novo mutations in
the offspring of each trio. We applied stringent control
for genotyping quality, and found that the sequencing
depth and mapping quality at these de novo variants are
not significantly lower than the genome-wide level, and
most of them (94.5%) are located outside the simple re-
peats region (Additional file 1: Fig. S1). We also filtered
out the mutations with allele balance ≤0.3 or ≥ 0.7.
Therefore, the de novo mutations identified could be
considered in the germline (see Methods). The number
of de novo SNVs ranged in 37–62 for each offspring
(listed in Additional file 1: Table S11). Correspondingly,
the germline de novo mutation rate was estimated to be
0.81 × 10− 8-1.33 × 10− 8 per site per generation for SNVs
(Table 2), which falls within the expected range [15, 48].
As listed in Additional file 1: Table S11, there were a
total of 242 de novo SNVs in the five offsprings, affect-
ing 137 genes, of which 108 were protein-coding genes.
These genes showed significant functional enrichment in
epidermal growth factor (8 of the 108 genes, Additional
file 2: Table S4). All the de novo SNVs were individual-
specific, but we found two mutations in MDQ (Chr2:
141,474,240) and Dusun (DSN) (Chr2:141,657,309) fall-
ing in the same gene, LRP1B, which encodes for a mem-
ber of the low-density lipoprotein receptor family. In
Fig. 1 Characterization of SNVs and indels identified in the 15 genomes. a Heterozygosity proportion of SNVs (green) and indels (pink) identified
from 15 individuals. The number of homozygous alternative variants and heterozygous variants for each population were calculated separately.
The heterozygosity proportion was calculated as the number of heterozygous variants divided by the sum of the number of homozygous
alternative variants and heterozygous variants. b Proportion of novel SNVs (green) and novel indels (pink) in all 15 individuals with the mean
mapped depth. c Number of SNVs with different impacts per sample. (d) Number of indels with different impacts per sample
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addition, CACNA1C and SLC43A2 were affected by mul-
tiple de novo SNVs in MRT. Two adjacent intronic allele
substitutions (at positions 2,605,335 and 2,605,336, re-
spectively; both were novel mutations) occurred in
CACNA1C. This gene encodes a subunit of voltage-
dependent calcium channel, and plays important roles in
a wide range of biological functions, e.g. muscle contrac-
tion, hormone or neurotransmitter release, gene expres-
sion, cell motility, cell division and cell death, and might
be attributed with cardiovascular diseases. Other inter-
esting de novo SNVs include a ‘modifier’ C > T substitu-
tion at rs72668090 in EGLN3 and a T > C mutation at
position 84,692,399 in NRG3 in the MDQ offspring.
Both genes were reported to function in cardiovascular
diseases [49, 50].
Compared with SNVs, the de novo mutation events
for indels occurred less frequently. The mutation rate
was estimated to be 1.0 × 10− 9-2.9 × 10− 9 per site per
generation according to the 4–10 de novo indels identi-
fied in each offspring (Table 2; Additional file 1: Table
S12), in accordance with previous reports [14, 52]. We
did not observe any direct physical or functional attribu-
tion between the de novo indels and de novo SNVs in
each sample – they were located distant from each other
(> 1Mb) and in different genes. A candidate gene of
interest affected by a de novo indel was CDH13 in the
Murut (MRT) offspring. CDH13 is a member of GPI-
anchored member of the cadherin superfamily, which
encodes for the protein T-cadherin that is prominently
expressed in heart. It is associated with blood pressure
regulation, atherosclerosis protection and regulation of
adiponectin level [52, 53]. Interestingly, this gene was
also reported to be associated with malaria susceptibility
[54], and consistently exerted as a signature of positive
selection in the Negrito populations from Peninsular
Malaysia [17, 18].
Analysis of copy number variants
To minimize potential false positive calls, we utilized
both ERDS and CNVnator to identify CNVs on the in-
dividual level (see Methods). Consequently, 9152 CNVs
over 100 bp in size were detected in the 15 samples,
including 7470 deletions and 1682 duplications. Each
sample carries 551–777 CNVs (610 on average)
(Additional file 1: Table S13). The number of CNVs
identified in each genome was similar (~ 1700), except
that the MDQ trio was observed to carry a higher num-
ber of CNVs (2172). The size distribution of CNVs is
shown in Fig. 2a. Deletions were enriched in the length
of 461 bp (43 deletions), and duplications were enriched
in the length of 1 kb (458 duplications). The largest
CNV was a duplication found in the MRT trio, span-
ning 529 kb at 18q11.2. It encompassed RBBP8, which
encodes for protein that regulates cell cycles and prolif-
eration [55]. Using the 50% reciprocal overlap criteria
to compare with the Database for Genome Variants
(DGV), a substantial amount of the CNVs identified (~
22.1%; 742 deletions and 1276 duplications) are previ-
ously unreported, of which 1214 (13%) were recurrent
(observed in at least 2 out of the 15 genomes studied).
These novel CNVs were enriched in size range < 1 kb
for deletions and in 1–10 kb for duplications. In the
total of 9152 CNVs, 42% (3832) were genic variants,
disrupting 694 genes (i.e, CNV breakpoints fell within
the exons; average 139 genes per genome). We ob-
served a large number of duplications (copy number
(CN) > 2) in this study, which suggests that the duplica-
tion events may have been under-reported in previous
array-based platforms, likely due to the limitation of
the nature of the technology. We observed 1–4 de novo
CNVs in each offspring, which converts to a mutation
rate of ~ 0.001, consistent with the range of the re-
ported rate (Table 2; Additional file 1: Table S14) [48].
All the 12 de novo CNVs were deletions ranging in
281–2778 bp. Two candidate genes of interest affected
by the de novo CNVs were LMF1 and CLDN14 identi-
fied in MDQ and DSN, respectively. LMF1 encodes for
protein lipase maturation factor, which involves in mat-
uration and transport of lipase. CLDN14 encodes an in-
tegral membrane protein and a component for tight
junction strands regulating the cell-cell adhesion in epi-
thelial or endothelial cell sheets.
Table 2 Autosomal de novo mutation rates for SNV, indel and CNV in each trio
Population SNV Indel CNV
# de novo
mutations
Mutation rate
(10−8)
# de novo
mutations
Mutation rate
(10− 8)
# de novo
mutations
# total
mutations
Mutation rate
Bateq 49 1.08 5 0.13 2 1754 0.001
Mendriq 37 0.81 10 0.29 1 2172 0.0005
Semai 40 0.86 6 0.15 3 1722 0.002
Dusun 54 1.2 4 0.1 4 1727 0.002
Murut 62 1.33 8 0.21 2 1777 0.001
The mutation rates (per site per generation) for SNV and indel were estimated using a callability-based approach (see Methods), and that for CNV was calculated
as the number of de novo mutations divided by the total mutations
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We then investigated the CNV sharing among the
native Malaysian trios, and grouped them as Orang
Asli CNVs (OA-CNVs; shared by BTQ, MDQ and
Semai (SMI)), Negrito CNVs (NGO-CNVs; shared by
BTQ and MDQ), North Bornean CNVs (NB-CNVs;
shared by DSN and MRT), and Malaysian CNVs
(MLS-CNVs; shared by OA and NB populations). As
expected, populations that are historically closer
tended to share more CNVs. For instance, we ob-
served more CNV regions shared within OA popula-
tion (302 OA-CNVs) and within NB population (386
NB-CNVs), than those shared between these two
groups (227 MLS-CNVs) (Fig. 2b; Additional file 4:
Table S15). Candidate genes affected by the OA-CNVs
were enriched in the synapse-related ion transduction
(Additional file 2: Table S4).
We further investigated the inheritance of several
candidate genes of interest that were known to either
lie on the segmental duplication region, or carry mul-
tiple allelic CNVs. Numerous studies have reported the
attributions and roles of CNVs underlying these genes
in a wide range of disease traits. Genes affected by
those reported CNVs are listed in Additional file 1:
Table S16, including: CCL3L1, DEFA/B, FCGR2/3,
AMY1/2, GSTT/GSTM, LPA, and CYP2D6 [56–65].
The copy number of these candidate genes were sur-
prisingly lower than average as previously reported [57,
58, 60, 66]. All five trios showed duplication (copy
number = 3) in AMY and DEFB103A (except MRT) but
a deletion (copy number = 1) in gene DEFB130. BTQ
and MDQ showed duplication for the DEFA1B gene
(copy number > 2) but not the rest of the trios. The
most variable gene among all trio members were LPA,
ranging in 4 (DSN) -10 (MDQ). Some of the copy num-
ber of these candidate genes of interest were not called,
probably due to the stringent quality control criteria
during the SV call, which had filtered out the ‘noisy’
calls. Validation is recommended for identifying these
copy number variants harbouring the complex and seg-
mental duplicated regions [57, 67–69].
Fig. 2 Structural variants identified in the 5 trios. a The number and length distribution of the duplications (left) and deletions (right) in each trio.
b Venn diagrams represented the number of shared and unique SVs among three OA trios (left), within two NB trios (medium) and between
these two groups (right)
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Novel insertions shared with archaic hominids
Novel insertions (NIs) (fragment size in 47–19,045 bp)
to the human reference genome have been identified in
the native Malaysian genomes. To avoid possible arte-
facts in sequencing and variants calling, we only focused
on the inherited NIs that was present in the offspring
and at least one of his/her parent. The number of inher-
ited autosomal NIs in OA (5984–6145 in each trio) was
slightly more than that in NB (5979–5991 in each trio),
probably due to the ancient origin and long-term isola-
tion of the OA hunter-gatherers. A full list of inherited
NIs can be found in Additional file 5: Table S17. We
found 547 of these NIs were unique to the OA, and 205
were unique to NB. Interestingly, 45.2–46.4% of the NIs
in each sample could also be observed in the Neander-
thal or Denisovan genomes (Table 3). Consistent with
the lower proportion of Denisovan-like genomic seg-
ments in the native Malaysian populations [23], only
around 50 of the archaic-like NIs in each sample could
be specifically observed in the Denisovan genome; while
the Neanderthal-like segments constituted a large pro-
portion of the archaic-like NIs. Enrichment analysis re-
vealed that genes underlying Neanderthal-like segments
are enriched for synapse-related cell junction, immunity,
ion channel, etc. (Additional file 2: Table S4).
Discussion
This study presents for the first time, a comprehensive
catalogue of genomic variants of the native trio inhabi-
tants from Peninsular Malaysia and North Borneo. Al-
though whole-genome sequencing has been commonly
applied in population genomic studies, very few publica-
tions have reported on ‘healthy’ trios [14, 15, 51], and of
particular interest are the lack of data on deep-
sequenced trios of native inhabitants such as the Orang
Asli and North Borneans. Identification of variants and
the frequencies of these populations could provide better
insights to population-specific disease susceptibility and
serve as an important stepping-stone for advancing
clinical and public health genomic study [70]. Studying
trios allows us to confirm rare and putatively population
specific variants that are often of clinical importance but
under-represented, since they are being transmitted,
therefore of high confidence.
On a separate note, sequencing of trios remains the
most straightforward strategy to estimate de novo muta-
tion rate [15]. This is crucial to date the evolutionary
events and to investigate the underlying causes for gen-
etic diseases [10]. We caution that de novo mutations
may be affected by paternal age [71, 72], which was not
available in our data. However, the estimated rate of de
novo mutations observed in this study is in line with
other recent studies [15, 48], and is not likely to be
affected by sequencing error or low mapping quality
(Additional file 1: Figure S1, Table S11-S12). De novo
mutations are often thought to undergo a different na-
ture of selective pressure and are more deleterious than
the inherited variants, thus, are more likely to be the
causative factor for many diseases [27, 48]. The de novo
SNVs in the genomes studied here (Table 2) were
enriched in genes related to EGF related pathways. Earl-
ier study have shown that EGF receptor pathway may
show adaptive changes against micro-environmental
forces specifically hypoxia, acidosis and reactive oxygen
species, thus able to induce genetic instability [73].
Haplotype phasing on trios using identity by descent
(IBD) essentially is thought to be more informative and
accurate than the phasing of unrelated individuals
based on the haplotype frequency information [74, 75].
When both parents are genotyped, variants that are not
triply heterozygous in the parents and offspring could
be phased. The IBD-based phasing using the trios of
this study, along with the population haplotype fre-
quency models, could be used as a reference and ap-
plied to additional populations, especially the Southeast
Asians. It works particularly for imputing variants with
low frequency. The task of phasing in isolated popula-
tions is somewhat a special case, as individuals from
such populations exhibit much higher levels of related-
ness, and tend to share much longer stretches of IBD-
sequences than a pair of unrelated individuals from a
non-isolated population.
Higher discovery rate of novel variants was observed
in the trio genomes from Peninsular Malaysia and
North Borneo compared to the global populations
(Table 2) possibly implies an insufficient coverage of
population diversity in the attempt of unveiling the
genome architecture. Therefore, more sequencing at-
tempts on the indigenous and more diversified popula-
tions (in particular the Southeast Asia region) should
be carried out in the near future.
In line with the genetic relationship among the native
Malaysian populations, more CNVs were shared among
Table 3 Inherited novel insertions in the 5 native Malaysian
trios
Population # Total
NIs
# Archaic-like
NIs
# Neanderthal-
like NIs
# Denisovan-
like NIs
Bateq 5984 2765 1873 48
Mendriq 6145 2776 1889 49
Semai 6010 2790 1920 47
Dusun 5991 2741 1862 49
Murut 5979 2742 1859 52
Archaic-like NIs, NIs that could be found in the Neanderthal or Denisovan
genomes; Neanderthal-like NIs, archaic-like NIs that could be specifically found
to the Neanderthal genome; Denisovan-like NIs, archaic-like NIs that could be
specifically found to the Denisovan genome
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OA populations and among NB populations than across
the two groups. Our functional enrichment analyses sug-
gested that the genes underlying CNVs in OA differed
from those in NB. The OA-specific CNVs were enriched
in genes involved in immunity; whereas the NB-specific
CNVs were enriched in protein secretory related path-
ways, suggesting possibility of different population his-
tory between these two different groups. In addition, we
observed putatively NIs shared with the archaic hominid
in the OA and NB populations, and they are significantly
enriched in post-synapse membrane and Pleckstrin
homology-like domain. Given the potential roles of the
underlying candidate genes, collectively these enrich-
ments imply that archaic hominin introgression may
have helped to shape the specificity of the native Malay-
sian populations, and could possibly affect the regulation
of immune response of these populations. Further inves-
tigations are warranted in order to provide further in-
sights to the evolutionary process of immune systems of
anatomical modern humans.
Several limitations were acknowledged in this study.
First, recruitment of trios from the natives like OA and
NB has been challenging because their population size is
small, and identification of the biological matched trio
members had been rather difficult. This limitation in-
deed hindered population-based analyses of this study.
Second, there is a gap to precisely identify breakpoints
of the CNVs called, due to the limitation of technology
and power of the analysis tools.
Conclusions
In this paper, we analyzed the deep-sequenced ge-
nomes of five native trios from Peninsular Malaysia
and North Borneo, and presents a full catalogue of
the genome variants. It has several important implica-
tions to regional human population genetics. First, the
higher discovery rate of novel variants in our ge-
nomes, although with a small sample size, compared
to global populations suggested insufficient coverage
of population diversity in the existing map of genomic
variations, hence emphasizing the necessity of con-
ducting further genomic studies on ‘minor’ popula-
tions of the world, such as the native inhabitants
from Malaysia. Second, the estimated mutation rate
and accurate phasing of the trio haplotypes could po-
tentially be used as a reference to genomic studies of
similar populations. Third, the differentiation of OA
and NB genomes imply discrepant demographic his-
tory of these two populations, in accordance with pre-
vious studies [20]. Last, the inherited novel insertions
with shared with archaic hominids identified in our
samples may imply unique population history of the
native inhabitants in Malaysia.
Methods
Sample collection and genome sequencing
Fifteen peripheral blood samples consisting of five sets of
trios (father-mother-offspring) were collected from
Malaysia under the approval of the Research and Ethics
Committee of Universiti Teknologi MARA [Ref no: 600-
RMI (5/1/6)], the Department of Orang Asli Development
(Jabatan Kemajuan Orang Asli Malaysia, JAKOA)
[JHEOA.PP.30.052.Jld 5(17)], and the Universiti Malaysia
Sabah Medical Research Ethics Committee [code: JKEtika
4/10(3)], as well as the district offices, village chief, and
the chairperson of the Committee of Village Development
and Security. Informed written consent was obtained from
the volunteers aged 18 years and above. Their family his-
tory, pedigree, and self-reported ethnicity were recorded
via an interview using local dialect. These five trios were
from five native groups (one for each). Three of them were
from Peninsular Malaysia, including Bateq (BTQ),
Mendriq (MDQ) (both are the Negrito tribes) and the
Semai (SMI) (Senoi) groups. They are collectively known
as Orang Asli (OA). The other two were from North
Borneo (abbreviated as NB population), including Dusun
(DSN) and Murut (MRT) populations. The information of
the trios is listed in Additional file 1: Table S1. The sam-
pling procedure, as well as the protocol for genome se-
quencing were described in detail in Yew et al. (2018)
[23]. Briefly, genomic DNA was isolated from peripheral
samples using DNeasy Blood and Tissue kit (Qiagen,
Hilden, Germany), and the integrity met the whole gen-
ome sequencing requirement (OD 260/280 reading ran-
ging from 1.8–2.2). These samples were sequenced using
Illumina HiSeq 2000, with a mean coverage of 30× (range
28–38×), targeted for 100 bp paired-end reads, with insert
sizes of 300–400 bp according to the manufacturer’s
instruction.
Read mapping and variant calling
Briefly, the pair-end reads in fastQ files were mapped to
human reference genome GRCh37 with BWA 0.7.5a
[24], and were subsequently merged and sorted to BAM
format using samtools 0.1.16 [25]. Low quality reads and
potential duplicates produced by the polymerase chain
reaction in the library construction were removed. We
then realigned the reads mapped around potential small
insertion or deletions using GATK 2.2–3 [26], and reca-
librated the base quality scores. Reads with mapping
quality (MQ) larger than 30 were kept for trio-aware
variants calling with unified genotyper module in
GATK2. Details of variants calling can be found in Yew
et al. (2018) [23].
Identification of de novo SNVs and indels
A variant in the offspring was defined as a de novo one
if it presents in neither parent but in the offspring of a
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trio. In detail, it should meet the following criteria: i)
the locus did not fall in the regions with poor mapp-
ability, low complexity or with enriched aberrant
SNPs (as reported by Mallick et al.) [2]; ii) the read
depth at this locus should be between 10 and 120,
and 30–70% of the reads should support the alterna-
tive allele (allele balance in 0.3–0.7), as suggested by
Kong et al. [27] and Neale et al. [28], to remove pu-
tative CNV regions in the offspring where the reads
from highly similar regions are often mixed together;
iii) the genotype quality of the variant should be ≧ 50
in both offspring and parents; iv) no read supports
the alternative allele in each parent; and v) the alter-
native allele should be absent from both parents but
present in the offspring.
Identification of copy number variants (CNVs)
We defined autosomal CNVs in this study as deleted or
duplicated DNA segments larger than 100 bp to distin-
guish it from the indels (< 100 bp). CNVs were identified
using CNVnator [29] and ERDS [30] in combination as
recommended by Trost el al. (2018) [31]. A filtered set
of CNVs was then generated by removing those variants
that were: i) identified by only one method (< 50% over-
lap); ii) overlapped with any repetitive and low-
complexity regions; or iii) with ≥50% overlap with gaps
and segmental duplications.
Identification of novel and de novo CNVs
A novel CNV was defined if it had < 50% overlap with a
CNV region reported in the Database for Genome Vari-
ants (DGV) (http://dgv.tcag.ca/dgv/app/home, GRCh37
[32]). We defined a de novo CNV as a deletion or dupli-
cation that was only present in the offspring but absent
in both parents. The following steps of stringent criteria
were used to identify de novo CNVs: (i) we compared
whether the putative CNV in the offspring was present
in his/her parents with consistent type (i.e copy number
gain or copy number loss) under the reciprocal overlap-
ping threshold of 50%; (ii) CNV that was not found in
step (i) were genotyped by CNVnator in the trios, and
we then filtered out the variants of which the genotyping
results were consistent in the trios; (iii) we subsequently
manually checked all the remaining CNVs in the last
step to confirm if the variant was indeed true de novo.
Estimating the de novo mutation rate
We calculated de novo mutation rate for SNVs and
indels in each trio based on a callability-based method in
which the probability of each site that can be called as a
de novo mutation is considered in denominator rather
than simple counts of sites [15]. For a site s with an ac-
tual de novo mutation, the callability Ck(s) is defined by
the probability of calling s as a de novo mutation in the
family k. The de novo mutation rate of a family k is
μk ¼
de novo mutaions in family kj j
2Ps∈sitesCk sð Þ
For CNVs, the de novo mutation rate was calculated
as the number of de novo CNVs divided by the total
CNVs in the offspring and averaged across trios.
Analysis of novel insertions
We used PopIns [33] with default settings to assemble
the human reference genome (GRCh37) unmapped
reads from the five trios into contigs together with those
unmapped reads from the archaic hominin genome se-
quences (e.g., Neanderthal and Denisovan, obtained
from http://cdna.eva.mpg.de/neandertal/altai/) [34, 35].
These assembled contigs were candidate novel se-
quences which were absent from the human reference
genome. We further filtered out the novel sequences in
the trios if they violated Mendelian inheritance as they
are more likely to be false positives.
Variants annotation and functional enrichment analysis
Annotation of the variants (SNVs, indels and CNVs) were
performed using SnpEff version 4.3 T [36], which provide
estimated biological effects for each variant. Functional
enrichment analysis of each set of gene was conducted
using the database for annotation, visualization and inte-
grated discovery (DAVID) v6.8 [37]. Enrichment score >
1.3, as proposed by the authors [37], and Benjamini-FDR-
corrected p value < 0.05 were considered as thresholds of
significance.
Haplotype phasing
Parent-trio haplotype phasing was carried out using
SHAPEIT for the five trios [5]. SHAPEIT allows for
the inference of haplotypes using identity-by-descent
(IBD) at any sized pedigrees. Prior to the haplotype
phasing, we removed 39,429 SNPs, 31,657 indels, and
77 CNVs with missing rate > 10% in the fifteen sam-
ples or exhibiting Mendelian error in two or more
trios. For each trio, SNVs, indels and CNVs were
phased in a combined dataset.
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